Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Butter themed license plates? Listeria outbreak in nursing homes? $20M in frozen farmer funds released? Check out these ...

With a rising number of pet owners and increased spending, the pet industry is demonstrating strong growth potential.

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...

The US Department of Agriculture last week issued a conditional license for an avian flu vaccine for use in chickens, as an ...

Both of these metrics are at their most attractive levels in the company's history, making this a once-in-a-decade opportunity. Its discounted price combined with a long track record of steady growth, ...

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...

This was the stock's third consecutive day of gains.

As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine By India Edwards HealthDay Reporter TUESDAY, Feb.

Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...

Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...

Q4 2024 Management View CEO Kristin Peck highlighted Zoetis delivered an excellent 2024, achieving double-digit operational revenue growth of 11% and adjusted net income growth of 15%. U.S. and ...